Warby Parker (WRBY) Total Non-Current Liabilities (2020 - 2026)
Warby Parker (WRBY) posted Total Non-Current Liabilities of $359.0 million for Q1 2026, up 2.03% on a QoQ basis from $351.9 million in Q4 2025, and up 9.67% year-over-year from $327.4 million in Q1 2025.
Warby Parker (WRBY) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Warby Parker's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $359.0 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 9.67% year-over-year to $359.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.0 million (up 9.67% YoY) and the FY2025 annual result came in at $351.9 million, up 4.89% from the prior year.
- Total Non-Current Liabilities was $359.0 million for Q1 2026 at Warby Parker, up from $351.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $359.0 million in Q1 2026 and bottomed at $258.2 million in Q2 2023.
- A 5-year average of $296.6 million and a median of $280.4 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 81.31% — and 2023, when it fell 1.12%.
- Warby Parker's Total Non-Current Liabilities stood at $280.4 million in 2022, then dropped by 1.12% to $277.3 million in 2023, then advanced by 21.0% to $335.5 million in 2024, then advanced by 4.89% to $351.9 million in 2025, then grew by 2.03% to $359.0 million in 2026.
- Business Quant data shows WRBY's Total Non-Current Liabilities at $359.0 million in Q1 2026, $351.9 million in Q4 2025, and $336.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Warby Parker | 3.00 Bn | 2.71 Bn | 131.04 Mn | 359.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 359.03 Mn |
| Dec 31, 2025 | 351.88 Mn |
| Sep 30, 2025 | 335.95 Mn |
| Jun 30, 2025 | 339.28 Mn |
| Mar 31, 2025 | 327.39 Mn |
| Dec 31, 2024 | 335.47 Mn |
| Sep 30, 2024 | 300.22 Mn |
| Jun 30, 2024 | 287.72 Mn |
| Mar 31, 2024 | 275.53 Mn |
| Dec 31, 2023 | 277.26 Mn |
| Sep 30, 2023 | 268.91 Mn |
| Jun 30, 2023 | 258.18 Mn |
| Mar 31, 2023 | 259.96 Mn |
| Dec 31, 2022 | 280.39 Mn |
| Sep 30, 2022 | 264.37 Mn |
| Jun 30, 2022 | 259.60 Mn |
| Mar 31, 2022 | 261.57 Mn |
| Dec 31, 2021 | 154.65 Mn |
| Sep 30, 2021 | 165.33 Mn |
| Dec 31, 2020 | 133.33 Mn |